Abeona Therapeutics Inc.

ABEO

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0000318306

SEC filings (opens in a new tab)

In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Abeona Therapeutics Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of ABEO: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Q4 2023	Change
Holders	40	48	+8
Shares	12.5M	14.1M	+1.66M (+13.3%)
Value	$52.5M	$70.8M	+$18.3M (+34.9%)

New holders (14)

Institutions that held Abeona Therapeutics Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to ABEO in Q4 2023
Institution	Shares	Value	% of portfolio
Ikarian Capital, LLC	600,000	$3.01M	0.82%
Walleye Capital LLC	188,016	$942.0K	0.01%
Boothbay Fund Management, LLC	160,260	$802.9K	0.03%
EAM Investors, LLC	97,809	$490.0K	0.09%
Citadel Advisors LLC	91,120	$456.5K	0.00%
Two Sigma Investments, LP	56,948	$285.3K	0.00%
Bank of America Corp	51,073	$255.9K	0.00%
Marshall Wace, LLP	47,856	$239.8K	0.00%
Jane Street Group, LLC	40,887	$204.8K	0.00%
Jump Financial, LLC	39,757	$199.2K	0.01%
Y-Intercept (Hong Kong) Ltd	10,414	$52.2K	0.00%
Squarepoint Ops LLC	10,000	$50.1K	0.00%
Qube Research & Technologies Ltd	1,785	$8.94K	0.00%
Northwestern Mutual Wealth Management Co	60	$301	0.00%

Sold out (6)

Institutions that held Abeona Therapeutics Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of ABEO in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Schonfeld Strategic Advisors LLC	153,930	$648.0K
Creative Planning	14,005	$59.0K
Gsa Capital Partners LLP	11,638	$49.0K
Dimensional Fund Advisors LP	11,196	$47.1K
UBS Group AG	1,061	$4.47K
Cambridge Trust Co	13	$55